Skip to main content
PMC home page
Clinical Cardiology logoLink to Clinical Cardiology
. 2006 Dec 5;27(5):300–303. doi: 10.1002/clc.4960270513

Beneficial effect of candesartan treatment on cardiac autonomic nervous activity in patients with chronic heart failure: Simultaneous recording of ambulatory electrocardiogram and posture

Keiichi Tambara 1, Masatoshi Fujita 2,✉, Yoshiyuki Sumita 3, Shoichi Miyamoto 4, Hiroyuki Sekiguchi 5, Shigeru Eiho 5, Masashi Komeda 1
PMCID: PMC6654212  PMID: 15188948

Abstract

Background: Reclining in the right lateral decubitus position in chronic heart failure (CHF) is a self‐protective mechanism for normalizing impaired cardiac autonomic nervous activity (CANA).

Hypothesis: Candesartan, an angiotensin II receptor blocker, exerts beneficial effects on CANA and postural preferences in patients with CHF.

Methods: We studied 15 patients with CHF due to coronary artery disease. Cardiac autonomic nervous activity was assessed using spectral heart rate variability (HRV) analysis based on 24‐h ambulatory electrocardiogram monitoring before and after an 8‐week treatment with candesartan. The patients' posture was simultaneously recorded using a specially devised detector, as the right (R) or left (L) lateral decubitus or supine (S) positions, to evaluate postural modulations of CANA. Normalized high‐frequency (0.15 to 0.40 Hz) power (nHF) and the low‐frequency (0.04 to 0.15 Hz)/high‐frequency power ratio (LF/HF) were used as indices of vagal activity and sympathovagal balance, respectively.

Results: When HRV was analyzed in each position, CANA was changed in L and S, but not in R, from sympathetic to parasympathetic prevalence by the treatment (R, nHF, 50 ± 20 vs. 52 ± 19 nu, p = 0.87; LF/HF, 1.39 ± 1.11 vs. 1.32 ± 1.32, p = 0.93; L, nHF, 28 ± 13 vs. 47 ± 19 nu, p = 0.019; LF/HF, 3.34 ± 2.48 vs. 1.56 ± 1.39, p = 0.029; S, nHF, 38 ± 17 vs. 53 ±16 nu, p = 0.0023; LF/HF, 2.43 ± 2.21 vs. 1.03 ± 0.59, p = 0.025). The fractions of the time in R and L were decreased and increased, respectively, by the treatment (R, 40 ± 30 vs. 18 ± 24%, p = 0.0018; L, 11 ± 20vs. 27 ± 26%, p = 0.025).

Conclusions: In patients with CHF, candesartan treatment improves cardiac autonomic balance, and the preference for the right lateral decubitus position disappears afterthe treatment.

Keywords: ambulatory electrocardiogram, angiotensin II type 1 receptor antagonist, chronic heart failure, heart rate variability

Full Text

The Full Text of this article is available as a PDF (46.3 KB).

References

  • 1. Crozier I, Ikram H, Awan N, Cleland J, Stephen N, Dickstein K, Frey M, Young J, Klinger G, Makris L, Rucinska E: Losartan in heart failure: Hemodynamic effects and tolerability. Circulation 1995; 91: 691–697 [DOI] [PubMed] [Google Scholar]
  • 2. Pitt B, Segal R, Martinez FA, Meurers G, Cowley AJ, Thomas I, Deedwania PC, Ney DE, Snavely DB, Chang PI: Randomised trial of losartan versus captopril in patients over 65 with heart failure (Evaluation of Losartan in the Elderly Study, ELITE). Lancet 1997; 349: 747–752 [DOI] [PubMed] [Google Scholar]
  • 3. McKelvie RS, Yusuf S, Pericak D, Avezum A, Burns RJ, Probstfield J, Tsuyuki RT, White M, Rouleau J, Latini R, Maggioni A, Young J, Pogue J: Comparison of candesartan, enalapril, and their combination in congestive heart failure: Randomized evaluation of strategies for left ventricular dysfunction (RESOLVD) pilot study. Circulation 1999; 100: 1056–1064 [DOI] [PubMed] [Google Scholar]
  • 4. Pitt B, Poole‐Wilson PA, Segal R, Martinez FA, Dickstein K, Camm AJ, Konstam MA, Riegger G, Klinger GH, Neaton J, Sharma D, Thiyagarajan B: Effect of losartan compared with captopril on mortality in patients with symptomatic heart failure: Randomised trial—the Losartan Heart Failure Survival Study ELITE II. Lancet 2000; 355: 1582–1587 [DOI] [PubMed] [Google Scholar]
  • 5. Häuser W, Dendorfer A, Nguyen T, Dominiak P: Effects of the AT1 antagonist HR 720 in comparison to losartan on stimulated sympathetic outflow, blood pressure, and heart rate in pithed spontaneously hypertensive rats. Kidney Blood Press Res 1998; 21: 29–35 [DOI] [PubMed] [Google Scholar]
  • 6. Dendorfer A, Raasch W, Tempel K, Dominiak P: Interactions between the renin‐angiotensin system (RAS) and the sympathtic system. Basic Res Cardiol 1998; 93 (suppl 2): 24–29 [DOI] [PubMed] [Google Scholar]
  • 7. Floras JS: Clinical aspects of sympathetic activation and parasympathetic withdrawal in heart failure. J Am Coll Cardiol 1993; 22 (suppl A): 72A–84A [DOI] [PubMed] [Google Scholar]
  • 8. Fujita M, Miyamoto S, Sekiguchi H, Eiho S, Sasayama S: Effects of posture on sympathetic nervous modulation in patients with chronic heart failure. Lancet 2000; 356: 1822–1823 [DOI] [PubMed] [Google Scholar]
  • 9. Miyamoto S, Fujita M, Sekiguchi H, Okano Y, Nagaya N, Ueda K, Tamaki S, Nohara R, Eiho S, Sasayama S: Effects of posture on cardiac autonomic nervous activity in patients with congestive heart failure. J Am Coll Cardiol 2001; 37: 1788–1793 [DOI] [PubMed] [Google Scholar]
  • 10. Inoko M, Fujita M, Nakae I, Tamaki T, Watanuki M, Hashimoto T, Konishi T: Effects of angiotensin‐converting enzyme inhibition on sympathetic tone in patients with mild to moderate heart failure. Jpn Circ J 2001; 65: 395–398 [DOI] [PubMed] [Google Scholar]
  • 11. Task Force of the European Society of Cardiology and the North American Society of Pacing and Electrophysiology. Heart rate variability : Standards of measurement, physiological interpretation, and clinical use. Circulation 1996; 93: 1043–1065 [PubMed] [Google Scholar]
  • 12. Koizumi K, Terui N, Kollai M: Effect of cardiac vagal and sympathetic nerve activity on heart rate in rhythmic fluctuations. J Auton Nerv Syst 1985; 12: 251–259 [DOI] [PubMed] [Google Scholar]
  • 13. Pagani M, Lombardi F, Guzzetti S, Rimoldi O, Furlan R, Pizzinelli P, Sandrone G, Malfatto G, Dell'Orto S, Piccaluga E: Power spectral analysis of heart rate and arterial pressure variabilities as a marker of sympathovagal interaction in man and conscious dog. Circ Res 1986; 59: 178–193 [DOI] [PubMed] [Google Scholar]
  • 14. Ashino K, Gotoh E, Sumita S, Takasaki I, Sugimoto K, Shionoiri H, Ishii M: Effect of an angiotensin receptor agonist, TCV‐116, on sympathetic nerve activity in patients with essential hypertension. Blood Press 1994; 3 (suppl 5): 122–129 [PubMed] [Google Scholar]
  • 15. Pancera P, Presciuttini B, Sansone S, Montagna L, Paluani F, Covi G, Lechi A: Effect of losartan on heart rate and blood pressure variability during tilt test and trinitroglycerine vasodilation. J Hypertens 1999; 17: 513–521 [DOI] [PubMed] [Google Scholar]
  • 16. Petretta M, Spinelli L, Marciano F, Apicella C, Vicario ML, Testa G, Volpe M, Bonaduce D: Effects of losartan treatment on cardiac autonomic control during volume loading in patients with DCM. Am J Physiol Heart Circ Physiol 2000; 279: H86–H92 [DOI] [PubMed] [Google Scholar]
  • 17. Zhang YH, Song YC, Zhu J, Hu TH, Wan LL: Effects of enalapril on heart rate variability in patients with congestive heart failure. Am J Cardiol 1995; 76: 1045–1048 [DOI] [PubMed] [Google Scholar]
  • 18. Flapan AD, Nolan J, Neilson JM, Ewing DJ: Effect of captopril on cardiac parasympathetic activity in chronic cardiac failure secondary to coronary artery disease. Am J Cardiol 1992; 69: 532–535 [DOI] [PubMed] [Google Scholar]
  • 19. Townend JN, West JN, Davies MK, Littler WA: Effect of quinapril on blood pressure and heart rate in congestive heart failure. Am J Cardiol 1992; 69: 1587–1590 [DOI] [PubMed] [Google Scholar]
  • 20. Baran D, Horn EM, Hryniewicz K, Katz SD: Effects of beta‐blockers on neurohormonal activation in patients with congestive heart failure. Drugs 2000; 60: 997–1016 [DOI] [PubMed] [Google Scholar]

Articles from Clinical Cardiology are provided here courtesy of Wiley

RESOURCES